147 related articles for article (PubMed ID: 33564266)
1. Long Non-Coding RNA (lncRNA) RAMS11 Promotes Metastatis and Cell Growth of Prostate Cancer by CBX4 Complex Binding to Top2α.
Zheng Z; Qiu K; Huang W
Cancer Manag Res; 2021; 13():913-923. PubMed ID: 33564266
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA RAMS11 promotes metastatic colorectal cancer progression.
Silva-Fisher JM; Dang HX; White NM; Strand MS; Krasnick BA; Rozycki EB; Jeffers GGL; Grossman JG; Highkin MK; Tang C; Cabanski CR; Eteleeb A; Mudd J; Goedegebuure SP; Luo J; Mardis ER; Wilson RK; Ley TJ; Lockhart AC; Fields RC; Maher CA
Nat Commun; 2020 May; 11(1):2156. PubMed ID: 32358485
[TBL] [Abstract][Full Text] [Related]
3. The Role of LINC01564, RAMS11, CBX4 and TOP2A in Hepatocellular Carcinoma.
Badr EAE; Elmongy EI; Mostafa RG; El-Sayed IE; Abd El-Ati Gad Allah AE; Khairy Ahmed A; Elghobashy YAS
Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672564
[TBL] [Abstract][Full Text] [Related]
4. RAMS11 promotes CRC through mTOR-dependent inhibition of autophagy, suppression of apoptosis, and promotion of epithelial-mesenchymal transition.
Islam Khan MZ; Law HKW
Cancer Cell Int; 2021 Jun; 21(1):321. PubMed ID: 34174900
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA FAM66C is associated with clinical progression and promotes cell proliferation by inhibiting proteasome pathway in prostate cancer.
Xie Y; Gu J; Qin Z; Ren Z; Wang Y; Shi H; Chen B
Cell Biochem Funct; 2020 Dec; 38(8):1006-1016. PubMed ID: 32430927
[TBL] [Abstract][Full Text] [Related]
7. High lncRNA HULC expression is associated with poor prognosis and promotes tumor progression by regulating epithelial-mesenchymal transition in prostate cancer.
Zheng P; Li H; Xu P; Wang X; Shi Z; Han Q; Li Z
Arch Med Sci; 2018 Apr; 14(3):679-686. PubMed ID: 29765457
[TBL] [Abstract][Full Text] [Related]
8. Long Non-coding RNA AGAP2-AS1 Silencing Inhibits PDLIM5 Expression Impeding Prostate Cancer Progression
Xie P; Liu M; Chen F; Wu S; Shao T; Wang W; Xu C; Zhou H
Front Genet; 2020; 11():1030. PubMed ID: 33101368
[TBL] [Abstract][Full Text] [Related]
9. Up-regulated long non-coding RNA ILF3-AS1 indicates poor prognosis of nasopharyngeal carcinoma and promoted cell metastasis.
Yang X; Lin F; Gao F
Int J Biol Markers; 2020 Dec; 35(4):61-70. PubMed ID: 32962500
[TBL] [Abstract][Full Text] [Related]
10. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
[TBL] [Abstract][Full Text] [Related]
11. The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype.
Thomas PB; Jeffery P; Gahete MD; Whiteside E; Walpole C; Maugham M; Jovanovic L; Gunter J; Williams E; Nelson C; Herington A; Luque RM; Veedu R; Chopin LK; Seim I
PeerJ; 2021; 9():e10280. PubMed ID: 33585078
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA UBE2CP3 promotes tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
Cao SW; Huang JL; Chen J; Hu YW; Hu XM; Ren TY; Zheng SH; Lin JD; Tang J; Zheng L; Wang Q
Oncotarget; 2017 Sep; 8(39):65370-65385. PubMed ID: 29029437
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.
Fan L; Li H; Wang W
Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850
[TBL] [Abstract][Full Text] [Related]
14. High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer.
Ke L; Xu SB; Wang J; Jiang XL; Xu MQ
Clin Transl Oncol; 2017 May; 19(5):599-605. PubMed ID: 27878433
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/ Smad signaling pathway.
Zhao B; Lu YL; Yang Y; Hu LB; Bai Y; Li RQ; Zhang GY; Li J; Bi CW; Yang LB; Hu C; Lei YH; Wang QL; Liu ZM
Cancer Biomark; 2018 Feb; 21(3):613-620. PubMed ID: 29278879
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis.
Yang YX; Wei L; Zhang YJ; Hayano T; Piñeiro Pereda MDP; Nakaoka H; Li Q; Barragán Mallofret I; Lu YZ; Tamagnone L; Inoue I; Li X; Luo JY; Zheng K; You H
Clin Exp Metastasis; 2018 Mar; 35(3):109-121. PubMed ID: 29948648
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer.
Zhang G; Li S; Lu J; Ge Y; Wang Q; Ma G; Zhao Q; Wu D; Gong W; Du M; Chu H; Wang M; Zhang A; Zhang Z
Mol Cancer; 2018 May; 17(1):87. PubMed ID: 29720189
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis.
Lin L; Gu ZT; Chen WH; Cao KJ
Diagn Pathol; 2015 Mar; 10():14. PubMed ID: 25889788
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway.
Liu W; Zhan J; Zhong R; Li R; Sheng X; Xu M; Lu Z; Zhang S
Technol Cancer Res Treat; 2021; 20():1533033821990074. PubMed ID: 33641529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
